Moller; Carsten

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moller; Carsten.The latest application filed is for "selective progesterone receptor modulators (sprm) and stabilized estrogen level in patient".

Company Profile

0.21.19

Moller; Carsten - Berlin DE
Moller; Carsten - Slagelse N/A DK
Moller; Carsten - Giessen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient Grant 10,485,808 - Schultze-Mosgau , et al. Nov	2019-11-26
Selective Progesterone Receptor Modulators (sprm) And Stabilized Estrogen Level In Patient App 20180369257 - SCHULTZE-MOSGAU; Marcus-Hillert ; et al.	2018-12-27
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases Grant 10,155,004 - Schwede , et al. Dec	2018-12-18
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases Grant 9,717,739 - Schwede , et al. August 1, 2	2017-08-01
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl Derivatives, Method Of Production Thereof And Use Thereof For The Treatment Of Diseases App 20170202857 - SCHWEDE; Wolfgang ; et al.	2017-07-20
Valve for controlling the liquid flow in a plant for central heating Grant 9,234,596 - Pedersen , et al. January 12, 2	2016-01-12
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases Grant 9,206,219 - Klar , et al. December 8, 2	2015-12-08
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl Derivatives, Method Of Production Thereof And Use Thereof For The Treatment Of Diseases App 20150342962 - SCHWEDE; Wolfgang ; et al.	2015-12-03
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases Grant 9,156,877 - Klar , et al. October 13, 2	2015-10-13
Progesterone receptor antagonists Grant 9,109,004 - Schwede , et al. August 18, 2	2015-08-18
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases Grant 9,102,701 - Klar , et al. August 11, 2	2015-08-11
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases Grant 9,096,639 - Klar , et al. August 4, 2	2015-08-04
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases Grant 9,096,640 - Klar , et al. August 4, 2	2015-08-04
Progesterone receptor antagonists Grant 9,085,603 - Schwede , et al. July 21, 2	2015-07-21
Valve App 20140191148 - Pedersen; Gitte ; et al.	2014-07-10
6,7-dihydro-5h-benzo[7]annulene Derivatives, Process For Preparation Thereof, Pharmaceutical Preparations Comprising Them, And The Use Thereof For Production Of Medicaments App 20130252890 - Wintermantel; Tim ; et al.	2013-09-26
Progesterone Receptor Antagonists App 20130072464 - Schwede; Wolfgang ; et al.	2013-03-21
Progesterone Receptor Antagonists App 20130005697 - Schwede; Wolfgang ; et al.	2013-01-03
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene Derivatives, Methods For The Production Thereof And Use Thereof For Treating Diseases App 20120316145 - Klar; Ulrich ; et al.	2012-12-13
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl Derivatives, Methods For The Production Thereof And The Use Thereof For Treating Diseases App 20120258941 - Klar; Ulrich ; et al.	2012-10-11
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases Grant 8,278,469 - Schwede , et al. October 2, 2	2012-10-02
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene Phenyl Derivatives, Methods For The Production Thereof And Use Thereof For Treating Diseases App 20120232042 - Klar; Ulrich ; et al.	2012-09-13
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl Derivatives, Methods For The Production Thereof And Use Thereof For Treating Diseases App 20120190660 - Klar; Ulrich ; et al.	2012-07-26
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene Oxyalkylene Aryl Derivatives, Process For Preparation Thereof, And Use Thereof For Treatment Of Diseases App 20120184515 - Klar; Ulrich ; et al.	2012-07-19
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl Derivatives, Method Of Production Thereof And Use Thereof For The Treatment Of Diseases App 20120149670 - Schwede; Wolfgang ; et al.	2012-06-14
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl Derivatives, Method Of Production Thereof And Use Thereof For The Treatment Of Diseases App 20120094969 - SCHWEDE; Wolfgang ; et al.	2012-04-19
Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19- -nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders App 20110112057 - Fuhrmann; Ulrike ; et al.	2011-05-12
Hip kinase for fertility control App 20090238836 - SACHER; FRANK ; et al.	2009-09-24
System for writing magnetic scales Grant 6,850,139 - Dettmann , et al. February 1, 2	2005-02-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.